Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Prepaid Assets: 2016-2024

Historic Prepaid Assets for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Dec 2024 value amounting to $5.8 million.

  • Rocket Pharmaceuticals' Prepaid Assets fell 19.21% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 19.21%. This contributed to the annual value of $5.8 million for FY2024, which is 15.85% up from last year.
  • Rocket Pharmaceuticals' Prepaid Assets amounted to $5.8 million in FY2024, which was up 15.85% from $5.0 million recorded in FY2023.
  • Rocket Pharmaceuticals' 5-year Prepaid Assets high stood at $7.7 million for FY2022, and its period low was $3.3 million during FY2021.
  • In the last 3 years, Rocket Pharmaceuticals' Prepaid Assets had a median value of $5.8 million in 2024 and averaged $6.2 million.
  • As far as peak fluctuations go, Rocket Pharmaceuticals' Prepaid Assets soared by 130.97% in 2022, and later plummeted by 34.16% in 2023.
  • Rocket Pharmaceuticals' Prepaid Assets (Yearly) stood at $4.6 million in 2020, then decreased by 28.25% to $3.3 million in 2021, then spiked by 130.97% to $7.7 million in 2022, then tumbled by 34.16% to $5.0 million in 2023, then climbed by 15.85% to $5.8 million in 2024.